Virginia Code § 59.1-293.20 established a directory-based system for regulating liquid nicotine and nicotine vapor products. Beginning December 31, 2025, only products listed in an Attorney General–maintained directory could be sold in the Commonwealth.
Retailers were given a 60-day sell-through period for existing inventory, ending in March 2026.
On paper, that deadline has passed.
In practice, retail shelves across Virginia remain largely unchanged. Brands, flavors, and disposable vape devices still line store displays in familiar packaging.
But a closer look at labeling shows a shift in what is actually being sold.
Most products now carry small-print labels reading “0mg nicotine” or “nicotine free,” and no longer display the standard federal warning that nicotine is an addictive chemical. Instead, they use broader disclaimers such as “This product may be addictive and intended for adult use only. Do not use if pregnant or nursing.”
Across multiple retail locations, these products list the active ingredient as “nixodine.”
The name closely resembles “nicotine” in both spelling and presentation. Based on available labeling and distributor descriptions, “nixodine” appears to refer to (S)-6-methylnicotine, a synthetic nicotine analog designed to interact with the same receptor pathways as nicotine.
Unlike traditional nicotine, synthetic nicotine analogs are not consistently addressed under existing tobacco product definitions. As a result, these products fall outside certain regulatory classifications, laws, and enforcement frameworks.
There is currently limited publicly available research on inhalation exposure to compounds such as (S)-6-methylnicotine. While some formulations reference food-grade additive classifications (“GRAS”), those designations apply to ingestion and do not evaluate safety for inhalation.
The result is a retail environment that appears visually unchanged following the March enforcement deadline, despite a documented shift in labeling and product composition.